Literature DB >> 2826683

[3H]neurotensin(8-13) binds in human brain to the same sites as does [3H]neurotensin but with higher affinity.

K S Kanba1, S Kanba, A Nelson, H Okazaki, E Richelson.   

Abstract

The binding of [3H]neurotensin(8-13) to membranes from human frontal cortex at 0 degree C was time dependent, specific, saturable, and reversible. Saturation isotherms provided an equilibrium dissociation constant (KD) of 0.52 nM, and the maximal number of binding sites (Bmax) was 3.5 pmol/g original wet weight of tissue. Scatchard analysis yielded a straight line, and the Hill coefficient was equal to 1, a result indicating that [3H]neurotensin(8-13) bound to single, noncoopertive sites. The KD values of several analogs of neurotensin determined in competition with [3H]neurotensin(8-13) were similar to those previously determined in competition with [3H]neurotensin. The regional distribution of binding sites for [3H]neurotensin(8-13) was also similar to that for [3H]neurotensin. These results suggest that [3H]neurotensin(8-13) binds to the same sites as [3H]neurotensin and that [3H]neurotensin(8-13) has a higher affinity than [3H]neurotensin for these sites in human brain.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2826683     DOI: 10.1111/j.1471-4159.1988.tb13239.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Rational design of novel neurotensin mimetics: discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonist.

Authors:  Y P Pang; J Zaidi; A P Kozikowski; B Cusack; E Richelson
Journal:  J Comput Aided Mol Des       Date:  1994-08       Impact factor: 3.686

2.  Glycosylated neurotensin analogues exhibit sub-picomolar anticonvulsant potency in a pharmacoresistant model of epilepsy.

Authors:  Hee-Kyoung Lee; Liuyin Zhang; Misty D Smith; H Steve White; Grzegorz Bulaj
Journal:  ChemMedChem       Date:  2009-03       Impact factor: 3.466

3.  The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).

Authors:  Paolo Di Fruscia; Yuanjun He; Marcel Koenig; Sahba Tabrizifard; Ainhoa Nieto; Patricia H McDonald; Theodore M Kamenecka
Journal:  Bioorg Med Chem Lett       Date:  2014-06-20       Impact factor: 2.823

4.  The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.

Authors:  Paul D Shilling; David Feifel
Journal:  Pharmacol Biochem Behav       Date:  2008-10       Impact factor: 3.533

5.  Facile solid phase peptide synthesis with a Re-lysine conjugate generated via a one-pot procedure.

Authors:  Kullapa Chanawanno; Joel Caporoso; Vinay Kondeti; Sailaja Paruchuri; Thomas C Leeper; Richard S Herrick; Christopher J Ziegler
Journal:  Dalton Trans       Date:  2014-05-30       Impact factor: 4.390

6.  Affinity of neuroleptics for D1 receptor of human brain striatum.

Authors:  S Kanba; E Suzuki; S Nomura; T Nakaki; G Yagi; M Asai; E Richelson
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.